Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
Schrödinger (Nasdaq: SDGR) will host a conference call and webcast on March 4, 2021, at 8:30 a.m. ET to discuss its fourth quarter and year-end 2020 financial results. The event will also provide a general business update. The live webcast can be accessed in the investors section of Schrödinger's website. Founded in 1990, Schrödinger employs over 450 people and utilizes a physics-based software platform to enhance the discovery of therapeutic and material innovations, aiming to accelerate development while lowering costs.
- Schrödinger's innovative software platform can significantly reduce development costs and time for drug discovery.
- The company has established a broad customer base, collaborating with over 450 clients across 70 countries.
- None.
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a conference call and webcast on Thursday, March 4, 2021, at 8:30 a.m. ET to discuss fourth quarter and year-end 2020 financial results and provide a general business update.
The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website. To participate in the live call, please dial (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 9686253. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
Founded in 1990, Schrödinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005045/en/
FAQ
What are the financial results Schrödinger will discuss on March 4, 2021?
How can I access the Schrödinger conference call?
What is Schrödinger's business focus?
